share_log

Ginkgo Bioworks | 144: Notice of proposed sale of securities pursuant to Rule 144

Ginkgo Bioworks | 144: Notice of proposed sale of securities pursuant to Rule 144

Ginkgo Bioworks | 144:擬議出售證券
SEC announcement ·  04/08 11:02
Moomoo AI 已提取核心訊息
Ginkgo Bioworks Holdings, Inc. officer Che Austin is set to sell 3,968 Class A shares of the company on 04/08/2024, as per the latest filing. These shares, valued at an aggregate market value of $4,245.76, were originally acquired on 10/07/2022 as part of a restricted stock vesting and were compensation for services rendered to the issuer. This upcoming transaction follows a series of sales over the past three months, where a total of 246,016 shares were sold for gross proceeds of approximately $309,900.80. The notice for the planned sale was filed on the same date as the sale, with the plan for this transaction having been adopted on 03/14/2023.
Ginkgo Bioworks Holdings, Inc. officer Che Austin is set to sell 3,968 Class A shares of the company on 04/08/2024, as per the latest filing. These shares, valued at an aggregate market value of $4,245.76, were originally acquired on 10/07/2022 as part of a restricted stock vesting and were compensation for services rendered to the issuer. This upcoming transaction follows a series of sales over the past three months, where a total of 246,016 shares were sold for gross proceeds of approximately $309,900.80. The notice for the planned sale was filed on the same date as the sale, with the plan for this transaction having been adopted on 03/14/2023.
根據最新文件,Ginkgo Bioworks Holdings, Inc.高管切·奧斯汀定於2024年8月4日出售該公司的3,968股A類股票。這些股票的總市值爲4,245.76美元,最初於2022年7月10日作爲限制性股票歸屬的一部分收購,是對向發行人提供的服務的補償。這筆即將進行的交易是在過去三個月進行了一系列銷售之後進行的,共出售了246,016股股票,總收益約爲309,900.80美元。計劃出售的通知與出售的同一天提交,該交易的計劃已於2023年3月14日獲得通過。
根據最新文件,Ginkgo Bioworks Holdings, Inc.高管切·奧斯汀定於2024年8月4日出售該公司的3,968股A類股票。這些股票的總市值爲4,245.76美元,最初於2022年7月10日作爲限制性股票歸屬的一部分收購,是對向發行人提供的服務的補償。這筆即將進行的交易是在過去三個月進行了一系列銷售之後進行的,共出售了246,016股股票,總收益約爲309,900.80美元。計劃出售的通知與出售的同一天提交,該交易的計劃已於2023年3月14日獲得通過。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息